DK1274399T3 - Liposomer indeholdende en indesluttet forbindelse i overmættet oplösning - Google Patents

Liposomer indeholdende en indesluttet forbindelse i overmættet oplösning

Info

Publication number
DK1274399T3
DK1274399T3 DK01906803T DK01906803T DK1274399T3 DK 1274399 T3 DK1274399 T3 DK 1274399T3 DK 01906803 T DK01906803 T DK 01906803T DK 01906803 T DK01906803 T DK 01906803T DK 1274399 T3 DK1274399 T3 DK 1274399T3
Authority
DK
Denmark
Prior art keywords
supersaturated solution
liposomes containing
encapsulated compound
compound
encapsulated
Prior art date
Application number
DK01906803T
Other languages
Danish (da)
English (en)
Inventor
Danilo D Lasic
Robert M Abra
Yechezkel Barenholz
Tal Peleg-Schulman
Original Assignee
Alza Corp
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp, Yissum Res Dev Co filed Critical Alza Corp
Application granted granted Critical
Publication of DK1274399T3 publication Critical patent/DK1274399T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
DK01906803T 2000-01-28 2001-01-26 Liposomer indeholdende en indesluttet forbindelse i overmættet oplösning DK1274399T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17865000P 2000-01-28 2000-01-28
PCT/US2001/003063 WO2001054666A1 (fr) 2000-01-28 2001-01-26 Liposomes contenant un compose piege place dans une solution sursaturee

Publications (1)

Publication Number Publication Date
DK1274399T3 true DK1274399T3 (da) 2005-08-08

Family

ID=22653355

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01906803T DK1274399T3 (da) 2000-01-28 2001-01-26 Liposomer indeholdende en indesluttet forbindelse i overmættet oplösning

Country Status (19)

Country Link
US (2) US20010033861A1 (fr)
EP (1) EP1274399B1 (fr)
JP (1) JP2003521366A (fr)
KR (2) KR20070089761A (fr)
CN (1) CN1236760C (fr)
AT (1) ATE292957T1 (fr)
AU (2) AU3467001A (fr)
CA (1) CA2398514A1 (fr)
DE (1) DE60110057T2 (fr)
DK (1) DK1274399T3 (fr)
ES (1) ES2236181T3 (fr)
HU (1) HUP0400628A3 (fr)
IL (2) IL150483A0 (fr)
MX (1) MXPA02007320A (fr)
NO (1) NO20023139L (fr)
NZ (1) NZ519856A (fr)
PT (1) PT1274399E (fr)
WO (1) WO2001054666A1 (fr)
ZA (1) ZA200205468B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1465590B1 (fr) * 2001-11-02 2008-03-26 The Governors Of The University Of Alberta Formulations contenant un lipide-polyethylene glycol
JP2005530704A (ja) * 2002-03-05 2005-10-13 トランセイブ， インク． 細胞内感染を予防及び治療するための吸入システム
US20040161481A1 (en) * 2002-12-18 2004-08-19 Algorx Administration of capsaicinoids
MXPA05006670A (es) * 2002-12-18 2005-10-19 Algorx Pharmaceuticals Inc Administracion de capsaicinoides.
US8980310B2 (en) * 2002-12-31 2015-03-17 Bharat Serums and Vaccines, Ltd. Non-pegylated long-circulating liposomes
AU2004233873B2 (en) 2003-04-25 2010-11-18 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
US20100034874A1 (en) * 2006-12-08 2010-02-11 Katayama Chemical Industries Co., Ltd. Liposome encapsulating ammine-platinum complex at high concentration, and method for production of the liposome
US8158682B2 (en) * 2008-09-12 2012-04-17 Vallinex, Inc. Instillation administration of capsaicinoids for the treatment of pain
JP5983608B2 (ja) * 2011-07-15 2016-09-06 コニカミノルタ株式会社 溶解助剤を利用したリポソーム含有製剤およびその製造方法
US9849087B2 (en) 2011-11-08 2017-12-26 The Board Of Trustees Of The University Of Arkansas Methods and compositions for X-ray induced release from pH sensitive liposomes
RU2014133467A (ru) 2012-02-17 2016-04-10 Селшн Корпорейшн Термочувствительные составы в виде наночастиц и способ их получения
US10039716B2 (en) * 2013-03-13 2018-08-07 Mallinckrodt Llc Liposomal cisplatin compositions for cancer therapy
CA2943049A1 (fr) 2014-04-08 2015-10-15 Aradigm Corporation Formulations de ciprofloxacine liposomale ayant une activite contre les mycobacteries non tuberculeuses
WO2015156904A1 (fr) * 2014-04-08 2015-10-15 Aradigm Corporation Liposomes formant des nanocristaux de médicament suite à congélation-décongélation
US20160120806A1 (en) * 2014-04-08 2016-05-05 Aradigm Corporation Nanocrystals formed in a microenvironment
WO2015166081A1 (fr) 2014-04-30 2015-11-05 Encapson B.V. Dispositifs médicaux à revêtements non uniformes pour une échogénicité améliorée
HK1258650A1 (zh) * 2015-09-14 2019-11-15 Vgsk Technologies, Inc. 皮下、舌下和口服治疗用空间稳定载体、用於治疗哺乳动物的组合物和方法
DE102017210700A1 (de) 2017-06-26 2018-12-27 Robert Bosch Gmbh Verfahren zum automatisierten Quantifizieren eines Analyten sowie NMR-Messgerät zur Durchführung des Verfahrens
US10925831B2 (en) * 2017-08-28 2021-02-23 Wake Forest University Liposomal formulations of platinum-acridine anticancer agents and methods thereof
WO2022235907A1 (fr) 2021-05-05 2022-11-10 Vgsk Technologies, Inc. Inhibition de la réplication du sars-cov-2 et réduction de l'inflammation pulmonaire par corticosteriods encapsulés dans des liposomes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3576117D1 (de) 1984-09-24 1990-04-05 Michael Mezei Mehrphasige pharmazeutische zusammensetzung.
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
DE69107844T2 (de) * 1990-04-18 1995-08-10 Takeda Chemical Industries, Ltd., Osaka Liposomenzusammensetzung.
EP0551169A1 (fr) * 1992-01-10 1993-07-14 Takeda Chemical Industries, Ltd. Composition de liposome et procédé de préparation
US5395619A (en) * 1993-03-03 1995-03-07 Liposome Technology, Inc. Lipid-polymer conjugates and liposomes
ATE220893T1 (de) * 1996-08-21 2002-08-15 Childrens Hosp Medical Center Hautaufhellungszusammensetzungen
ATE252372T1 (de) * 1996-08-23 2003-11-15 Sequus Pharm Inc Liposome enthaltend cisplatin
TW520297B (en) * 1996-10-11 2003-02-11 Sequus Pharm Inc Fusogenic liposome composition and method
CA2269758C (fr) * 1996-10-22 2008-01-08 Hermes Biosciences, Inc. Compositions liposomes comprenant des composes ionisables sous formes precipitees et leurs procedes de preparation
WO2001025223A1 (fr) * 1999-10-06 2001-04-12 The Research Foundation Of State University Of New York Stabilisation de systemes disperses contenant du taxane
CZ20022410A3 (cs) * 2000-01-31 2003-08-13 Pfizer Products Inc. Benzoanelované heterocyklylové deriváty nikotinamidu užitečné jako selektivní inhibitory isozymů PDE4

Also Published As

Publication number Publication date
DE60110057D1 (de) 2005-05-19
US20060159739A1 (en) 2006-07-20
KR20070089761A (ko) 2007-08-31
KR20030011767A (ko) 2003-02-11
EP1274399B1 (fr) 2005-04-13
ATE292957T1 (de) 2005-04-15
US20010033861A1 (en) 2001-10-25
CN1236760C (zh) 2006-01-18
DE60110057T2 (de) 2005-09-08
NO20023139L (no) 2002-09-23
AU2001234670B2 (en) 2005-05-19
IL150483A0 (en) 2002-12-01
KR100782891B1 (ko) 2007-12-06
PT1274399E (pt) 2005-07-29
US8062662B2 (en) 2011-11-22
CN1396822A (zh) 2003-02-12
ES2236181T3 (es) 2005-07-16
ZA200205468B (en) 2004-09-29
JP2003521366A (ja) 2003-07-15
HUP0400628A2 (hu) 2004-06-28
AU3467001A (en) 2001-08-07
IL150483A (en) 2008-07-08
NO20023139D0 (no) 2002-06-28
CA2398514A1 (fr) 2001-08-02
NZ519856A (en) 2004-03-26
MXPA02007320A (es) 2004-07-30
HUP0400628A3 (en) 2006-07-28
WO2001054666A1 (fr) 2001-08-02
EP1274399A1 (fr) 2003-01-15

Similar Documents

Publication Publication Date Title
DK1274399T3 (da) Liposomer indeholdende en indesluttet forbindelse i overmættet oplösning
NO20001012L (no) FremgangsmÕte for administrering av liposomalinnkapslet taxan
DE60111144D1 (de) Dauermagnetläufer
DE69810677D1 (de) Permanentmagnet-Synchronmotor
ID28329A (id) Komposisi-komposisi yang sesuai untuk sel-sel elektrokimia
DK1100469T3 (da) Hurtigt henfaldende fast præparat
AU2569399A (en) Radionuclide excited phosphorescent material for administering pdt
DE50014837D1 (de) Transversalflussmaschine
IT1228964B (it) Rotore per una macchina elettrica eccitata mediante magneti permanenti.
EP0784371A4 (fr) Piece polaire d'aimant permanent pour moteurs lineaires
DE60118982D1 (de) Seltenerdelement-permanentmagnetmaterial
DE60129506D1 (de) Herstellungsverfahren für Seltenerd-Dauermagneten
DE69939013D1 (de) Dauermagnetsynchronmaschine
FI980980A7 (fi) Kestomagneettitahtikone
FI971743A7 (fi) Liposomikoostumus, joka sisältää selegiliiniä
ATE345778T1 (de) (ester)-lysolecithine in liposomen
ITTO20010028A0 (it) Metodo per aumentare l'attivita' antitumorale di una sostanza contenente amigdalina, composizione contenente una sostanza con contenuto aume
IT1303173B1 (it) Macchina per la formatura di avvolgimenti per statori di macchinedinamo-elettriche e procedimento di formatura realizzato mediante
IT1266845B1 (it) Metodo per la fabbricazione di un rotore in un magnete.
AU2963299A (en) Magnet armature
AU2003278743A1 (en) Permanent magnet excited machine
AU2000239101A1 (en) A method of administering liposomal encapsulated taxane
AU2002216606A1 (en) Hibrid excitation motors
GB9910748D0 (en) Magnetising magnet
KR950031407U (ko) 4폴 마그네트